GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study — Stella

Recruiting

Back to Cardiovascular Diseases trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Key details

Sponsor

University of Alabama at Birmingham

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~200 participants

Started

April 2022

Primary completion

September 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov